A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

Fecal microbiota transplantation with an anaerobic cultivated human intestinal microbiome failed to improve gastrointestinal symptoms in patients with systemic sclerosis, a phase 2 study showed.

A thyroglobulin antibody (TgAb) test looks for certain antibodies that attack the thyroid. The presence of TbAb in high levels may indicate that someone has an autoimmune condition. To conduct a ...

LifeArc Ventures, which invests in innovative early-stage life science companies as part of LifeArc, today announced substantial progress ...

PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s ...

Botulinum toxin type A (BoNT-A), commonly known as Botox, has emerged as a promising option for managing multiple sclerosis (MS ... By targeting specific areas, Botox relaxes overactive muscles ...

Jeffrey V. Matous, MD, discusses how best practices in transitioning care between academic and community centers can enhance patient outcomes when receiving bispecific antibodies, and the critical ...

Long-term safety data in MS patients for the highly specific ... IgG4κ antibody raised against α4-integrin (CD49d) was approved for the treatment of relapsing-remitting multiple sclerosis ...

The type of scleroderma impacts the likelihood of specific facial symptoms, but all forms can cause tight, hard areas of skin, texture changes, discoloration, the appearance of blood vessels ...

Foralumab, a fully human anti-CD3 monoclonal antibody, is a biological drug candidate that has been shown to stimulate T regulatory cells when dosed intranasally. At present, 10 patients with ...